|
National Stock Number(NSN): 6505-01-371-6441 (6505013716441, 013716441)
| NIIN: |
01-371-6441 |
Item Name: |
ANTIHEMOPHILIC FACTOR |
INC: |
34428
|
| FSC: |
6505
|
Assignment Date: |
Feb-19-1993 |
CRIT: |
N |
IIG: |
34428 |
| ISC: |
5 |
Date Standardized: |
Feb-19-1993 |
HMIC: |
P |
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
Nov-20-2002 |
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
A93A026 |
66732
|
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMO-SA |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC49669-4300-02 |
66159
|
ALPHA THERAPEUTIC CORP |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
PROFILATE OSD |
66159
|
ALPHA THERAPEUTIC CORP |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
M |
U |
1 |
A |
$180.00 |
PG |
|
C2201X- |
Jul-01-1995 |
H |
| DF |
JDC |
L |
|
M |
U |
1 |
F |
$180.00 |
PG |
|
------- |
Jun-01-1995 |
H |
| DN |
JDC |
L |
|
M |
U |
1 |
N |
$180.00 |
PG |
|
9L----- |
Apr-01-1993 |
H |
| DS |
JDC |
L |
|
M |
U |
1 |
D |
$180.00 |
PG |
|
------- |
Feb-01-1993 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 12EA |
000 |
|
|
|
| DA |
R |
REFER TO NOT DMSB STZD |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 12EA |
000 |
|
|
|
| DF |
R |
REFER TO NON-STD NON-DMSB REV |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 12EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 12EA |
000 |
|
|
|
| DS |
R |
REFER TO NON-STD NON-DMSB REV |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
FREEZE-DRIED POWDER |
| AJCN |
PROTECTIVE STORAGE FEATURE |
SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL, SINGLE DOSE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1000.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT |
| FEAT |
SPECIAL FEATURES |
FACTOR VIII:C HUMAN;HEAT TREATED,AND/OR SOLUTION/DETERGENT CONCENTRATE;EACH VIAL PACKAGED W/SUFFICIENT DILUENT,STERILE FILTER NEEDLE AND ONE WINGED INFUSION SET;12 VIAL |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Feb-21-1993 |
0 |
0 |
|
|
|
|
| FSKX |
|
Feb-21-1993 |
0 |
0 |
|
|
|
|
| N9LM |
|
Feb-21-1993 |
0 |
0 |
|
|
|
|
|